Answers are grounded in this paper and cite their sources.
Introduction: Failure to wean or extubate patients on mechanical ventilation increases ICU stay, hospital costs and mortality. There are several protocols and scores developed to predict the extubation outcome, but the failure remains around 15%. ExPreS is a extubation predictive score published in 2021 (doi: 10.1371/journal.pone.0248868) and have been tested in a multicenter randomized clinical trial (RTC). Here, we present a partial analysis from one center. Objective: To compare the predictive capacity of the ExPreS versus the standard protocol on extubation outcome. Method: This RTC was carried out in the 2 ICU of a university hospital, with patients aged ≥18, on MV for more than 24 hours and in the process of weaning from MV. Patients were randomized to the control (CG) or ExPreS group (EG). The primary outcome was the extubation failure at 48 h. Results: 329 patients were randomized, and 41 excluded post randomization. From 288 patients, 147 were allocated in the CG, while 141 in the EG. The extubation failure rate was 12.9% in the CG and 7.8% in EG. When we excluded patients that failed due upper airway obstruction (UAO) (8 patients with stridor or laryngospasm), complications that the ExPreS does not predict, the extubation failure in the CG was 11.1%, while in the EG was 3.7% (p=0.022). Groups do not differ in sex distribution, age, diagnosis or APACHE II score, just as the group did not influence in ICU and hospital outcomes, MV duration, ICU stay and hospital stay. Conclusion: The analysis of the partial data, from a single center, showed that the use of ExPreS can decrease the extubation failure rate, mainly from causes non-related to UAO
No takes yet. Share an insight, caveat, or question.
Baptistella et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: